معرفی
Peter Gustenhoff serves as a Senior Physician (Overlæge) at Aalborg University Hospital within the Faculty of Medicine's Department of Endocrinology. His clinical and research work focuses on diabetes management, particularly insulin therapies and hypoglycemia prevention in type 1 diabetes patients.
His research interests center on diabetes therapeutics, with emphasis on comparative effectiveness of insulin analogs (Degludec vs. Glargine), nocturnal hypoglycemia prevention, and continuous glucose monitoring applications. The fingerprint analysis of his work shows strong concentration in pharmacological aspects of insulin therapy (100% Insulin Degludec, 90% Pig Insulin), diabetes pathophysiology (80% Insulin Dependent Diabetes Mellitus), and monitoring technologies (40% Continuous Glucose Monitoring).
Analysis of his recent publications reveals a consistent focus on clinical trials addressing hypoglycemia management in type 1 diabetes, particularly through advanced insulin formulations and monitoring technologies. His work demonstrates translational research bridging clinical practice and therapeutic innovation, with significant attention to patient subgroups prone to nocturnal severe hypoglycemia.
Gustenhoff actively engages with public discourse on diabetes care, as evidenced by media coverage of his perspectives on diabetes assistance technologies and healthcare access.
